82 results
Page 4 of 5
8-K
EX-10.6
j0saens5
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am
8-K
EX-2.2
r9xuo3h
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am
8-K
EX-2.1
g8fe5nr
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am
425
EX-10.6
en55bivsq2vbxqb
25 Jul 19
Business combination disclosure
6:36am
425
EX-2.2
insu50pe2k5
25 Jul 19
Business combination disclosure
6:36am
425
EX-2.1
v7nvd9 zvx9
25 Jul 19
Business combination disclosure
6:36am
8-K
EX-10.1
1io67idcdm1e 06wtaa8
6 Aug 18
Gemphire Provides Update On Development of Gemcabene
4:01pm
8-K
EX-10.1
kfla1v etf
6 Aug 18
Entry into a Material Definitive Agreement
4:01pm
DEFA14A
foumw093h
3 May 18
Additional proxy soliciting materials
4:40pm
8-K
EX-10.1
hjposjl0t9
3 May 18
Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer
4:18pm
8-K
b75p06x2lbjstmt
3 May 18
Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer
4:18pm
424B3
gbj58og zm692b6vf
21 Apr 17
Prospectus supplement
12:00am
10-K
zu2k p3gn
21 Mar 17
Annual report
12:00am